Metromicon-neo candles vaginal 500mg + 100mg №14

Indications

Vaginal infections:

- vaginal candidiasis;

- Trichomonas vaginitis and vulvovaginitis, bacterial vaginosis;

- mixed vaginal infection.

Dosage and administration

Intravaginally.

Acute vaginitis, bacterial vaginosis: 1 suppository in the morning and at night for 7 days in a row.

Chronic vaginitis: 1 suppository 1 time per day, immediately before bedtime, for 14 consecutive days.

Often recurrent vaginitis or in the absence of positive clinical dynamics in the treatment of other methods: 1 suppository in the morning and at night for 14 days.

Before freeing the suppository from the contour packaging using scissors (cut the film along the contour of the suppository), insert it deeply into the vagina.

Adverse effects

Local reactions: burning, itching, irritation of the mucous membrane of the vagina and increased swelling. Due to inflammation of the vaginal mucosa with vaginitis, irritation may increase after the introduction of the first suppository or by the third day of treatment. These complications quickly disappear after stopping treatment.

From the gastrointestinal tract: pain or cramps in the abdomen, "metallic" taste, dry mouth, constipation, diarrhea, loss of appetite, nausea, vomiting.

Nervous system: headache, motor disorders (ataxia), dizziness, psycho-emotional disorders, convulsions.

Hemic and lymphatic: leukopenia.

Allergic reactions: skin rashes, including urticaria.

Contraindications

- hypersensitivity to the components of the drug or other derivatives of nitroimidazole;

- I trimester of pregnancy, lactation,

- children's age up to 18 years;

- in virgins.

Carefully: with hepatic and renal failure, porphyria, impaired blood formation and diseases of the peripheral and central nervous system, diabetes, microcirculation disorders, during pregnancy (II and III trimesters).

Use during pregnancy and lactation

The purpose of the drug is contraindicated in the first trimester of pregnancy. Application in the II and III trimesters of pregnancy is possible only if the potential benefit to the mother outweighs the possible risk to the fetus.

If necessary, the appointment of the drug during lactation breastfeeding should be discontinued, since Metronidazole penetrates into breast milk. Breastfeeding can be resumed 24-48 hours after the end of treatment.

Application for violations of the liver

With caution in liver failure.

Application for violations of kidney function

With caution in renal failure.

Use in children

Contraindicated in children under 18 years.

Special notes

When using the drug should refrain from sexual contact. In order to avoid re-infection, simultaneous treatment of the sexual partner is necessary. In the case of Trichomonas vaginitis, it is advisable to simultaneously treat the sexual partner with oral metbnidazole.

During treatment and at least for 24-48 hours after the end of the course of treatment, ethanol administration should be avoided (ethanol intolerance is possible).

The simultaneous use of the drug with contraceptive diaphragms and condoms made of rubber or latex is not recommended (interaction with price suppositories is possible).

With strong irritation of the vagina, drug treatment should be discontinued.

Suppositories should be used only intravaginally, they can not be swallowed or used in another way.

In the case of the drug in conjunction with metronidazole for oral administration, especially with repeated courses, control of the pattern of peripheral blood is necessary (danger of leukopenia).

Influence on ability to drive motor transport and management of potentially dangerous mechanisms: It is recommended to be careful, as the possible negative impact on the ability to drive a car and control complex machinery cannot be excluded. If side effects arise from the central nervous system, one should refrain from driving and working with potentially dangerous machinery.

Overdosage

At observance of the recommended doses, due to the low absorption of the drug, overdose cases were not detected.

Possible symptoms: nausea, vomiting, abdominal pain, diarrhea, itching, metallic taste in the mouth, ataxia, dizziness, paresthesia, peripheral neuropathy (with prolonged use in high doses), convulsions, leukopenia, dark urine staining (due to an overdose of metronidazole).

Symptoms of miconazole overdose have not been identified.

Treatment: symptomatic and supportive therapy, with occasional ingestion - gastric lavage.

Drug interaction

In connection with the ingress of metronidazole into the systemic circulation, the following interaction reactions may be noted with simultaneous use with certain substances:

Oral anticoagulants: effect of indirect anticoagulants increases.

Disulfiram: there may be violations of the central nervous system (mental reactions); no, metronidazole should be prescribed to patients who have taken disulfiram in the last 2 weeks.

Phenytoin: the concentration of phenytoin in the blood increases, and the concentration of metronidazole in the blood decreases.

Lithium preparations: an increase in their toxicity may be observed.

Phenobarbital: decreases the concentration of metronidazole in the blood.

Cimetidine: may increase the concentration of metronidazole in the blood.

Astemizol and terfenadine: metronidazole and miconazole inhibit the metabolism of these drugs and increase plasma concentration.

Ethanol: The interaction of metronidazole with ethanol causes disulfiram-like reactions.

Pharmacy sales terms

On prescription.

Terms and conditions of storage

In a dry dark place at a temperature of from 15 to 25 ° C. Keep out of the reach of children.